| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |